eMedicine Specialties > Oncology > Gynecologic Carcinomas

Teratoma, Cystic

Author: Chad A Hamilton, MD, Associate Program Director, NCC Fellowship in Gynecologic Oncology, Assistant Professor, Division of Gynecologic Oncology, Walter Reed Army Medical Center
Coauthor(s): Margarett C Ellison, MD, Consulting Staff, Kaiser Permanente, Los Angeles Medical Center
Contributor Information and Disclosures

Updated: Jan 23, 2009

Introduction

Background

Teratomas are germ cell tumors commonly composed of multiple cell types derived from one or more of the 3 germ layers. Inconsistent nomenclature often confuses discussions of various subtypes of teratomas. The word is derived from the Greek teras, meaning monster, which Virchow coined in the first edition of his book on tumors published in 1863.1 Teratomas range from benign, well-differentiated (mature) cystic lesions to those that are solid and malignant (immature). Additionally, teratomas may be monodermal and highly specialized. Rarely, within some mature teratomas certain elements (most commonly squamous components) undergo malignant transformation.

In 1831, Leblanc coined the term dermoid cyst in the veterinary literature when he removed a lesion that resembled skin at the base of a horse's skull, which he called a “kyste dermoid.”2  Both dermoid and teratoma, terms now more than a century old, remain in general use and often are used interchangeably with various preferences among subspecialties. The earliest implications were that elements similar to skin and its appendages composed dermoids, while teratomas had no such limits. Dermoids now are recognized as often being trigerminal and containing practically any type of tissue.

For those who continue to make a distinction, dermoids are tumors that maintain rather orderly arrangements, with well-differentiated ectodermal and mesodermal tissues surrounding endodermal components. Teratomas, specifically solid teratomas, are essentially devoid of organization; thus, the presence of some degree of organization, a high degree of cellular differentiation, and cystic structure differentiates dermoids from teratomas.1 This article focuses on mature cystic teratomas, commonly referred to as dermoid cysts.

Mature cystic teratoma of the ovary exhibiting mu...

Mature cystic teratoma of the ovary exhibiting multiple tissue types.

Mature cystic teratoma of the ovary exhibiting mu...

Mature cystic teratoma of the ovary exhibiting multiple tissue types.




Mature cystic teratoma of the ovary with hair, se...

Mature cystic teratoma of the ovary with hair, sebaceous material, and thyroid tissue.

Mature cystic teratoma of the ovary with hair, se...

Mature cystic teratoma of the ovary with hair, sebaceous material, and thyroid tissue.


Pathophysiology

Teratomas are made up of a variety of parenchymal cell types representing more than 1 germ layer and often all 3. Arising from totipotential cells, these tumors typically are midline or paraxial.3  The most common location is sacrococcygeal (57%). Because they arise from totipotential cells, they are encountered commonly in the gonads (29%). By far, the most common gonadal location is the ovary, although they also occur somewhat less frequently in the testes. Cystic teratomas occasionally occur in sequestered midline embryonic cell rests and can be mediastinal (7%), retroperitoneal (4%), cervical (3%), and intracranial (3%).4  Cells differentiate along various germ lines, essentially recapitulating any tissue of the body. Examples include hair, teeth, fat, skin, muscle, and endocrine tissue (see Images 1-2).

Frequency

International

Sacrococcygeal teratomas are the most common tumors in newborns, occurring in 1 per 20,000-40,000 births.3,5

Mature cystic teratomas account for 10-20% of all ovarian neoplasms. They are the most common ovarian germ cell tumor and also the most common ovarian neoplasm in patients younger than 20 years. They are bilateral in 8-14% of cases.2,1,6,7

The incidence of all testicular tumors in men is 2.1-2.5 cases per 100,000 population. Germ cell tumors represent 95% of testicular tumors after puberty, but pure benign teratomas of the testis are rare, accounting for only 3-5% of germ cell tumors. The incidence of all testicular tumors in prepubertal boys is 0.5-2 per 100,000, with mature teratomas accounting for 14-27% of these tumors. It is the second most common germ cell tumor in this population.8,9

Benign teratomas of the mediastinum are rare, representing 8% of all tumors of this region.10

Mortality/Morbidity

Mature cystic teratomas can result in significant morbidity. Potential complications vary depending on the site of occurrence.

Sacrococcygeal teratoma

Sacrococcygeal teratomas are commonly diagnosed in the prenatal period, and complications may occur in utero or during or after birth. The outcome after antenatal diagnosis is significantly worse than that for older postnatal surgical series, with survival rates ranging from –54-77%.11,12,13
 
Potential complications in utero include polyhydramnios and tumor hemorrhage, which can lead to anemia and nonimmune hydrops fetalis. If significant atrioventricular shunting occurs within the tumor, hydrops may result from high-output cardiac failure. Development of hydrops is an ominous sign. If it develops after 30 weeks' gestation, the mortality rate is 25%. If it is recognized, delivery is recommended as soon as lung maturity is documented. Development of hydrops before 30 weeks' gestation has an abysmal prognosis, with a 93% mortality rate.11 Makin et al reported that antenatal intervention for the treatment of fetal hydrops did not improve outcomes with neonatal deaths in 6 (86%) of 7 cases.13 Hydrops and prematurity are the two main factors that contribute to mortality.

Postpartum morbidity associated with sacrococcygeal teratomas is attributable to associated congenital anomalies, mass effects of the tumor, recurrence, and intraoperative and postoperative complications. Ten to twenty-four percent of sacrococcygeal teratomas are associated with other congenital anomalies, primarily defects of the hindgut and cloacal region, which exceeds the baseline rate of 2.5% expected in the general population.14,15,3

In one larger series that included 57 cases of benign teratomas over a 40-year period from a single institution, 5 recurrences were documented. Only one of the patients who experienced recurrence did not undergo a coccygectomy, and one patient who was thought to have a benign tumor with immature elements was found to have embryonal carcinoma after the third excision. In this same series, 3 patients had postoperative wound infections and one patient had postoperative pneumonia. The overall survival was 95% and morbidity or mortality rates were consistent over the 40-year period of the study.5

In a more recent series, all 26 patients diagnosed with benign teratomas survived. Seven of 20 patients with long-term follow-up developed neuropathic bladder or bowel disturbances.15 A longitudinal cross-sectional follow-up study found that sequelae developing in childhood tended to improve with time, while functional symptoms reported in adulthood were common in the general population and not significantly increased over a control group.16

Ovarian teratoma

Complications of ovarian teratomas include torsion, rupture, infection, hemolytic anemia, and malignant degeneration.

Torsion is by far the most significant cause of morbidity, occurring in –3-11% of cases. Several series have demonstrated that increasing tumor size correlates with increased risk of torsion.2,17

Rupture of a cystic teratoma is rare and may be spontaneous or associated with torsion. Most series report a rate of less than 1%,2,1 though Ahan et al reported a rate of 2.5% in their report of 501 patients.18 Rupture may occur suddenly, leading to shock or hemorrhage with acute chemical peritonitis. Chronic leakage also may occur, with resultant granulomatous peritonitis. Prognosis after rupture is usually favorable, but the rupture often results in formation of dense adhesions.

Infection is uncommon and occurs in less than 1-2% of cases. Coliform bacteria are the organisms most commonly implicated.18,17

Autoimmune hemolytic anemia has been associated with mature cystic teratomas in rare cases. In these reports, removal of the tumor resulted in complete resolution of symptoms. Theories behind the pathogenetic mechanism include (1) tumor substances that are antigenically different from the host and produce an antibody response within the host that cross reacts with native red blood cells, (2) antibody production by the tumor directed against host red blood cells, and (3) coating of the red blood cells by tumor substance that changes red blood cell antigenicity. In this context, radiologic imaging of the pelvis may be indicated in cases of refractory hemolytic anemia.19,20

In its pure form, mature cystic teratoma of the ovary is always benign, but in approximately 0.2-2% of cases, it may undergo malignant transformation into one of its elements, the majority of which are squamous cell carcinomas. The prognosis for patients with malignant degeneration is generally poor but dependent on stage and degenerated cell type.2,21

Testicular teratoma

Testicular teratomas occur in children and adults, but their incidence and natural history contrast sharply. Pure teratomas comprise 38% of germ cell tumors in infants and children but only 3% after puberty. In children, they behave as a benign tumor, whereas in adults and adolescents they are known to metastasize.22,23 With no documented cases of metastasis, morbidity from prepubertal testicular teratomas is largely limited to surgical or postoperative complications.

During and after puberty, all teratomas are regarded as malignant because even mature teratomas (composed of entirely mature histologic elements) can metastasize to retroperitoneal lymph nodes or to other systems. Rates reported vary from 29-76%. Morbidity is associated with growth of the tumor, which may invade or obstruct local structures and become unresectable. Approximately 20% of patients relapse during surveillance.22

Mediastinal teratoma

Mature teratomas of the mediastinum, the most common mediastinal germ cell tumor, are benign lesions. They do not have the metastatic potential observed in testicular teratoma and are cured by surgical resection alone. Because of their anatomic location, intraoperative and postoperative complications are the only significant source of morbidity, as other intrathoracic structures are often intimately involved with the tumor.24

Sex

Sacrococcygeal teratomas are much more common in females than in males, occurring in a female-to-male ratio of approximately 3-4:1. Most sources report no sex predilection for mediastinal teratomas. Others document a marked male or marked female predominance. Excluding testicular teratomas, 75-80% of teratomas occur in girls.4

Age

The presenting location of teratomas correlates with age.

  • In infancy and early childhood, the most frequent location is extragonadal, whereas teratomas presenting after childhood more commonly are located in the gonads.25
  • An increasing number of patients with sacrococcygeal teratomas are diagnosed antenatally. In Gabra’s series this proportion increased from 11% before 1988 to 53% from 1988-2001. The majority of sacrococcygeal teratomas are diagnosed in the neonatal period. Patients presenting later tend to have less obvious external tumors and symptoms of bladder or bowel dysfunction often leads to diagnosis.15      
  • Cystic teratomas of the ovary can occur in persons of any age, although they are diagnosed most frequently during the reproductive years. The peak incidence in most series is age 20-40 years.18
  • Testicular teratomas may occur at any age but are more common in infants and children. In adults, pure testicular teratomas are rare, constituting 2-3% of germ cell tumors.22
  • Mediastinal teratomas can be found in persons of any age but occur most commonly in adults aged 20-40 years.10,26

Clinical

History

  • Sacrococcygeal teratoma: Sacrococcygeal teratomas may be diagnosed antenatally during routine ultrasounds, fetal anomaly scans, or when the mother presents with clinical symptoms such as size greater than dates or polyhydramnios.13 Those not diagnosed antenatally present in 2 patterns. The most common pattern is in neonates, who present with a large, predominantly benign tumor protruding from the sacral area that is noted prenatally or at the time of delivery. Less commonly, the newborn may exhibit only asymmetry of the buttocks or present when aged 1 month to 4 years with a presacral tumor that may extend into the pelvis. Symptoms of bladder or bowel dysfunction may be present. The latter group is at a significantly higher risk for malignancy.15

    Large teratomatous epignathus diagnosed by prenat...

    Large teratomatous epignathus diagnosed by prenatal ultrasound.

    Large teratomatous epignathus diagnosed by prenat...

    Large teratomatous epignathus diagnosed by prenatal ultrasound.

  • Ovarian teratoma: Mature cystic teratomas of the ovary are often discovered as incidental findings on physical examination, during radiographic studies, or during abdominal surgery performed for other indications. Asymptomatic mature cystic teratomas of the ovaries have been reported at rates of 6-65% in various series. When symptoms are present, they may include abdominal pain, mass or swelling, and abnormal uterine bleeding. Bladder symptoms, gastrointestinal disturbances, and back pain are less frequent. When abdominal pain is present, it usually is constant and ranges from slight to moderate in intensity. Torsion and acute rupture commonly are associated with severe pain. Hormonal production is thought to account for cases of abnormal uterine bleeding, but histologic examination has not provided evidence to support this theory.18,2,1

    A 12-cm mature cystic teratoma of the ovary prior...

    A 12-cm mature cystic teratoma of the ovary prior to excision.

    A 12-cm mature cystic teratoma of the ovary prior...

    A 12-cm mature cystic teratoma of the ovary prior to excision.

  • Testicular teratomas most often present as a painless scrotal mass, except in the case of torsion. In most cases, the masses are firm or hard, nontender, and do not transilluminate. Testicular pain and scrotal swelling are occasionally reported with teratomas, but this is nonspecific and simply indicates torsion until proven otherwise. Hydrocele is frequently associated with teratoma in childhood. On examination, the testis is diffusely enlarged, rather than nodular, although a discreet nodule in the upper or lower pole sometimes can be appreciated.27,28
  • Mediastinal teratomas are often asymptomatic. When symptoms are present, they relate to mechanical effects including chest pain, cough, dyspnea, or symptoms related to recurrent pneumonitis. Many patients present with respiratory findings, and the pathognomonic finding of trichoptysis, or cough productive of hair or sebaceous material, may result if a communication develops between the mass and the tracheobronchial tree. Other serious presentations are superior vena cava syndrome or lipoid pneumonia. Mediastinal teratomas are occasionally discovered incidentally on chest radiograph.29,4,10,26

Physical

See History.

Causes

The existence of teratomas has been recognized for centuries, during which time their origin was a matter of speculation and debate. Common early beliefs blamed ingestion of teeth and hair, as well as curses from witches, nightmares, or even adultery with the devil.1 The parthenogenic theory, which suggests an origin from the primordial germ cells, is now the most widely accepted. This theory is bolstered by the anatomic distribution of the tumors along lines of migration of the primordial germ cells from the yolk sac to the primitive gonads.3,30 Additional support came from Linder and associates' studies of mature cystic teratomas of the ovaries. They used sophisticated cytogenetic techniques to demonstrate that these tumors are of germ cell origin and arise from a single germ cell after the first meiotic division.31

More on Teratoma, Cystic

Overview: Teratoma, Cystic
Differential Diagnoses & Workup: Teratoma, Cystic
Treatment & Medication: Teratoma, Cystic
Follow-up: Teratoma, Cystic
Multimedia: Teratoma, Cystic
References

References

  1. Pantoja E, Noy MA, Axtmayer RW, Colon FE, Pelegrina I. Ovarian dermoids and their complications. Comprehensive historical review. Obstet Gynecol Surv. Jan 1975;30(1):1-20. [Medline].

  2. Comerci JT Jr, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol. Jul 1994;84(1):22-8. [Medline].

  3. Kumar V, Abbas AK, Fausto N. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia: Elsevier Saunders; 2005.

  4. Grosfeld JL, Billmire DF. Teratomas in infancy and childhood. Curr Probl Cancer. Sep 1985;9(9):1-53. [Medline].

  5. Schropp KP, Lobe TE, Rao B, et al. Sacrococcygeal teratoma: the experience of four decades. J Pediatr Surg. Aug 1992;27(8):1075-8; discussion 1078-9. [Medline].

  6. Stany MP, Hamilton CA. Benign disorders of the ovary. Obstet Gynecol Clin North Am. Jun 2008;35(2):271-84, ix. [Medline].

  7. Wu RT, Torng PL, Chang DY, et al. Mature cystic teratoma of the ovary: a clinicopathologic study of 283 cases. Zhonghua Yi Xue Za Zhi (Taipei). Oct 1996;58(4):269-74. [Medline].

  8. Rushton HG, Belman AB. Testis-sparing surgery for benign lesions of the prepubertal testis. Urol Clin North Am. Feb 1993;20(1):27-37. [Medline].

  9. Ulbright TM. Germ cell neoplasms of the testis. Am J Surg Pathol. Nov 1993;17(11):1075-91. [Medline].

  10. Lewis BD, Hurt RD, Payne WS, Farrow GM, Knapp RH, Muhm JR. Benign teratomas of the mediastinum. J Thorac Cardiovasc Surg. Nov 1983;86(5):727-31. [Medline].

  11. Flake AW, Harrison MR, Adzick NS, Laberge JM, Warsof SL. Fetal sacrococcygeal teratoma. J Pediatr Surg. Jul 1986;21(7):563-6. [Medline].

  12. Hedrick HL, Flake AW, Crombleholme TM, et al. Sacrococcygeal teratoma: prenatal assessment, fetal intervention, and outcome. J Pediatr Surg. Mar 2004;39(3):430-8; discussion 430-8. [Medline].

  13. Makin EC, Hyett J, Ade-Ajayi N, Patel S, Nicolaides K, Davenport M. Outcome of antenatally diagnosed sacrococcygeal teratomas: single-center experience (1993-2004). J Pediatr Surg. Feb 2006;41(2):388-93. [Medline].

  14. Altman RP, Randolph JG, Lilly JR. Sacrococcygeal teratoma: American Academy of Pediatrics Surgical Section Survey-1973. J Pediatr Surg. Jun 1974;9(3):389-98. [Medline].

  15. Gabra HO, Jesudason EC, McDowell HP, Pizer BL, Losty PD. Sacrococcygeal teratoma--a 25-year experience in a UK regional center. J Pediatr Surg. Sep 2006;41(9):1513-6. [Medline].

  16. Cozzi F, Schiavetti A, Zani A, Spagnol L, Totonelli G, Cozzi DA. The functional sequelae of sacrococcygeal teratoma: a longitudinal and cross-sectional follow-up study. J Pediatr Surg. Apr 2008;43(4):658-61. [Medline].

  17. Benjapibal M, Boriboonhirunsarn D, Suphanit I, Sangkarat S. Benign cystic teratoma of the ovary : a review of 608 patients. J Med Assoc Thai. Sep 2000;83(9):1016-20. [Medline].

  18. Ayhan A, Bukulmez O, Genc C, Karamursel BS, Ayhan A. Mature cystic teratomas of the ovary: case series from one institution over 34 years. Eur J Obstet Gynecol Reprod Biol. Feb 2000;88(2):153-7. [Medline].

  19. Buchwalter CL, Miller D, Jenison EL. Hemolytic anemia and benign pelvic tumors. A case report. J Reprod Med. Apr 2001;46(4):401-4. [Medline].

  20. Kim I, Lee JY, Kwon JH, et al. A case of autoimmune hemolytic anemia associated with an ovarian teratoma. J Korean Med Sci. Apr 2006;21(2):365-7. [Medline].

  21. Dos Santos L, Mok E, Iasonos A, et al. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol. May 2007;105(2):321-4. [Medline].

  22. Carver BS, Al-Ahmadie H, Sheinfeld J. Adult and pediatric testicular teratoma. Urol Clin North Am. May 2007;34(2):245-51; abstract x. [Medline].

  23. Walsh C, Rushton HG. Diagnosis and management of teratomas and epidermoid cysts. Urol Clin North Am. Aug 2000;27(3):509-18. [Medline].

  24. Dulmet EM, Macchiarini P, Suc B, Verley JM. Germ cell tumors of the mediastinum. A 30-year experience. Cancer. Sep 15 1993;72(6):1894-901. [Medline].

  25. Rowe MI, O'Neill JA, Grosfeld JL. Essentials of Pediatric Surgery. ed. St Louis, Mo: Mosby-Year Book; 1995.

  26. Moran CA, Suster S. Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging. Cancer. Aug 15 1997;80(4):681-90. [Medline].

  27. Garrett JE, Cartwright PC, Snow BW, Coffin CM. Cystic testicular lesions in the pediatric population. J Urol. Mar 2000;163(3):928-36. [Medline].

  28. Herr HW, LaQuaglia MP. Management of teratoma. Urol Clin North Am. Feb 1993;20(1):145-52. [Medline].

  29. Billmire DF, Grosfeld JL. Teratomas in childhood: analysis of 142 cases. J Pediatr Surg. Jun 1986;21(6):548-51. [Medline].

  30. Ulbright TM. Gonadal teratomas: a review and speculation. Adv Anat Pathol. Jan 2004;11(1):10-23. [Medline].

  31. Linder D, McCaw BK, Hecht F. Parthenogenic origin of benign ovarian teratomas. N Engl J Med. Jan 9 1975;292(2):63-6. [Medline].

  32. Patel MD, Feldstein VA, Lipson SD, Chen DC, Filly RA. Cystic teratomas of the ovary: diagnostic value of sonography. AJR Am J Roentgenol. Oct 1998;171(4):1061-5. [Medline].

  33. Varghese TK, Lau CL. The Mediastinum. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 18. Philadelphia, PA: Saunders Elsevier; 2007:chap 58.

  34. Chervenak FA, Isaacson G, Touloukian R, Tortora M, Berkowitz RL, Hobbins JC. Diagnosis and management of fetal teratomas. Obstet Gynecol. Nov 1985;66(5):666-71. [Medline].

  35. Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. Radiographics. Mar-Apr 2001;21(2):475-90. [Medline].

  36. Mais V, Guerriero S, Ajossa S, Angiolucci M, Paoletti AM, Melis GB. Transvaginal ultrasonography in the diagnosis of cystic teratoma. Obstet Gynecol. Jan 1995;85(1):48-52. [Medline].

  37. Scoutt LM, McCarthy SM, Lange R, Bourque A, Schwartz PE. MR evaluation of clinically suspected adnexal masses. J Comput Assist Tomogr. Jul-Aug 1994;18(4):609-18. [Medline].

  38. Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest. Oct 2005;128(4):2893-909. [Medline].

  39. Jeung MY, Gasser B, Gangi A, et al. Imaging of cystic masses of the mediastinum. Radiographics. Oct 2002;22 Spec No:S79-93. [Medline].

  40. Talerman A. Germ Cell Tumors of the Ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, NY: Springer-Verlag; 2002:chap 20.

  41. Cavenaile C, Reed J, Fiorito D. Ovarian teratoma with a high level of differentiation. South Med J. May 2001;94(5):522-3. [Medline].

  42. Graf JL, Albanese CT. Fetal sacrococcygeal teratoma. World J Surg. Jan 2003;27(1):84-6. [Medline].

  43. Koçak M, Dilbaz B, Ozturk N, et al. Laparoscopic management of ovarian dermoid cysts: a review of 47 cases. Ann Saudi Med. Sep-Oct 2004;24(5):357-60. [Medline].

  44. Laberge PY, Levesque S. Short-term morbidity and long-term recurrence rate of ovarian dermoid cysts treated by laparoscopy versus laparotomy. J Obstet Gynaecol Can. Sep 2006;28(9):789-93. [Medline].

  45. Nezhat CR, Kalyoncu S, Nezhat CH, Johnson E, Berlanda N, Nezhat F. Laparoscopic management of ovarian dermoid cysts: ten years' experience. JSLS. Jul-Sep 1999;3(3):179-84. [Medline].

  46. Templeman CL, Fallat ME, Lam AM, Perlman SE, Hertweck SP, O'Connor DM. Managing mature cystic teratomas of the ovary. Obstet Gynecol Surv. Dec 2000;55(12):738-45. [Medline].

  47. Ross JH, Kay R. Prepubertal testis tumors. Rev Urol. Winter 2004;6(1):11-8. [Medline].

  48. Rushton HG, Belman AB, Sesterhenn I, Patterson K, Mostofi FK. Testicular sparing surgery for prepubertal teratoma of the testis: a clinical and pathological study. J Urol. Sep 1990;144(3):726-30. [Medline].

  49. Shukla AR, Woodard C, Carr MC, Huff DS, Canning DA, Zderic SA. Experience with testis sparing surgery for testicular teratoma. J Urol. Jan 2004;171(1):161-3. [Medline].

  50. Caspi B, Levi R, Appelman Z, Rabinerson D, Goldman G, Hagay Z. Conservative management of ovarian cystic teratoma during pregnancy and labor. Am J Obstet Gynecol. Mar 2000;182(3):503-5. [Medline].

  51. Hess LW, Peaceman A, O'Brien WF, Winkel CA, Cruikshank DP, Morrison JC. Adnexal mass occurring with intrauterine pregnancy: report of fifty-four patients requiring laparotomy for definitive management. Am J Obstet Gynecol. May 1988;158(5):1029-34. [Medline].

  52. Parker WH, Childers JM, Canis M, Phillips DR, Topel H. Laparoscopic management of benign cystic teratomas during pregnancy. Am J Obstet Gynecol. May 1996;174(5):1499-501. [Medline].

Further Reading

Keywords

cystic teratoma, dermoid teratoma, dermoid cyst, ovarian cancer, ovarian cyst, ovarian malignancy, dermoid tumor, testicular cancer, testicular tumor, kyste dermoid, ovarian neoplasm, sacrococcygeal teratoma, dermoid, teratoma, dermoid cyst, mature cystic teratoma, monodermal

Contributor Information and Disclosures

Author

Chad A Hamilton, MD, Associate Program Director, NCC Fellowship in Gynecologic Oncology, Assistant Professor, Division of Gynecologic Oncology, Walter Reed Army Medical Center
Chad A Hamilton, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Obstetricians and Gynecologists, and Society of Gynecologist Oncologists
Disclosure: Nothing to disclose.

Coauthor(s)

Margarett C Ellison, MD, Consulting Staff, Kaiser Permanente, Los Angeles Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Lodovico Balducci, MD, Professor of Oncology and Medicine, University of South Florida College of Medicine; Division Chief, Senior Adult Oncology Program, H Lee Moffitt Cancer Center and Research Institute
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Benjamin Movsas, MD, Vice-Chairman, Department of Radiation Oncology, Fox Chase Cancer Center
Benjamin Movsas, MD is a member of the following medical societies: American College of Radiology, American Radium Society, and American Society for Therapeutic Radiology and Oncology
Disclosure: Nothing to disclose.

CME Editor

Rajalaxmi McKenna, MD, FACP, Southwest Medical Consultants, SC, Department of Medicine, Good Samaritan Hospital, Advocate Health Systems
Rajalaxmi McKenna, MD, FACP is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology, and International Society on Thrombosis and Haemostasis
Disclosure: Nothing to disclose.

Chief Editor

Jules E Harris, MD, Clinical Professor of Medicine, Division of Hematology/Medical Oncology, Department of Internal Medicine, University of Arizona College of Medicine at Tucson; Consulting Staff, Arizona Cancer Center
Jules E Harris, MD is a member of the following medical societies: American Association for Cancer Research, American Association for the Advancement of Science, American Association of Immunologists, American Society of Hematology, and Central Society for Clinical Research
Disclosure: GlobeImmune Salary Consulting; Amplimed Consulting fee Consulting; FibroGen Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.